293 related articles for article (PubMed ID: 35563725)
1. How to Make Sense out of 75,000 Mesenchymal Stromal Cell Publications?
Mönch D; Reinders MEJ; Dahlke MH; Hoogduijn MJ
Cells; 2022 Apr; 11(9):. PubMed ID: 35563725
[TBL] [Abstract][Full Text] [Related]
2. First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue.
Couto PS; Shatirishvili G; Bersenev A; Verter F
Regen Med; 2019 May; 14(4):309-319. PubMed ID: 31070115
[No Abstract] [Full Text] [Related]
3. The Unique Properties of Placental Mesenchymal Stromal Cells: A Novel Source of Therapy for Congenital and Acquired Spinal Cord Injury.
Kulubya ES; Clark K; Hao D; Lazar S; Ghaffari-Rafi A; Karnati T; Ebinu JO; Zwienenberg M; Farmer DL; Wang A
Cells; 2021 Oct; 10(11):. PubMed ID: 34831060
[TBL] [Abstract][Full Text] [Related]
4. Cryopreserved, Xeno-Free Human Umbilical Cord Mesenchymal Stromal Cells Reduce Lung Injury Severity and Bacterial Burden in Rodent Escherichia coli-Induced Acute Respiratory Distress Syndrome.
Curley GF; Jerkic M; Dixon S; Hogan G; Masterson C; O'Toole D; Devaney J; Laffey JG
Crit Care Med; 2017 Feb; 45(2):e202-e212. PubMed ID: 27861182
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy.
Krampera M; Le Blanc K
Cell Stem Cell; 2021 Oct; 28(10):1708-1725. PubMed ID: 34624232
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.
Ringdén O; Moll G; Gustafsson B; Sadeghi B
Front Immunol; 2022; 13():839844. PubMed ID: 35371003
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?
Owen A; Newsome PN
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(10):G791-800. PubMed ID: 26316587
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cell therapy for pancreatitis: Progress and challenges.
Ma Z; Zhou J; Yang T; Xie W; Song G; Song Z; Chen J
Med Res Rev; 2021 Jul; 41(4):2474-2488. PubMed ID: 33840113
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stromal Cells in Ischemic Brain Injury.
Brooks B; Ebedes D; Usmani A; Gonzales-Portillo JV; Gonzales-Portillo D; Borlongan CV
Cells; 2022 Mar; 11(6):. PubMed ID: 35326464
[TBL] [Abstract][Full Text] [Related]
10. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus.
Radmanesh F; Mahmoudi M; Yazdanpanah E; Keyvani V; Kia N; Nikpoor AR; Zafari P; Esmaeili SA
IUBMB Life; 2020 Nov; 72(11):2366-2381. PubMed ID: 33006813
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
Introna M; Golay J
Front Immunol; 2020; 11():609063. PubMed ID: 33362797
[TBL] [Abstract][Full Text] [Related]
12. Adult mesenchymal stromal stem cells for therapeutic applications.
Spitkovsky D; Hescheler J
Minim Invasive Ther Allied Technol; 2008; 17(2):79-90. PubMed ID: 18465443
[TBL] [Abstract][Full Text] [Related]
13. Critical factors responsible for the therapeutic effect of mesenchymal stem/stromal cells in central nervous system disorders.
Figiel-Dąbrowska A; Sypecka M; Chodkowska M; Sarnowska A
Folia Neuropathol; 2022; 60(1):1-9. PubMed ID: 35359141
[TBL] [Abstract][Full Text] [Related]
14. Genetically modified mesenchymal stromal cells in cancer therapy.
Sage EK; Thakrar RM; Janes SM
Cytotherapy; 2016 Nov; 18(11):1435-1445. PubMed ID: 27745603
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem/Stromal Cells Therapy for Sepsis and Acute Respiratory Distress Syndrome.
Byrnes D; Masterson CH; Artigas A; Laffey JG
Semin Respir Crit Care Med; 2021 Feb; 42(1):20-39. PubMed ID: 32767301
[TBL] [Abstract][Full Text] [Related]
16. Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.
Perico N; Casiraghi F; Remuzzi G
J Am Soc Nephrol; 2018 Feb; 29(2):362-375. PubMed ID: 29191959
[TBL] [Abstract][Full Text] [Related]
17. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs).
Prockop DJ
Clin Pharmacol Ther; 2007 Sep; 82(3):241-3. PubMed ID: 17700588
[TBL] [Abstract][Full Text] [Related]
18. Clinical Trials Using Mesenchymal Stem Cells for Spinal Cord Injury: Challenges in Generating Evidence.
de Araújo LT; Macêdo CT; Damasceno PKF; das Neves ÍGC; de Lima CS; Santos GC; de Santana TA; Sampaio GLA; Silva DN; Villarreal CF; Chaguri ACC; da Silva CG; Mota ACA; Badaró R; Ribeiro Dos Santos R; Soares MBP
Cells; 2022 Mar; 11(6):. PubMed ID: 35326470
[TBL] [Abstract][Full Text] [Related]
19. Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?
Galderisi U; Peluso G; Di Bernardo G
Stem Cell Rev Rep; 2022 Jan; 18(1):23-36. PubMed ID: 34398443
[TBL] [Abstract][Full Text] [Related]
20. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
Front Immunol; 2021; 12():643170. PubMed ID: 33732263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
